Description
Everolimus Tablet
Everolimus is approved for various conditions:
- Advanced kidney cancer (US FDA approved in March 2009)
- Prevention of organ rejection after renal transplant(US FDA April 2010)
- Subependymal giant cell astrocytoma (SEGA) associated with tuberous sclerosis (TS) in patients who are not suitable for surgical intervention (US FDA October 2010)
- Progressive or metastatic pancreatic neuroendocrine tumors not surgically removable (May 2011)
- Breast cancer in post-menopausal women with advanced hormone-receptor positive, HER2-negative type cancer, in conjunction with exemestane (US FDA July 2012)
- Prevention of organ rejection after liver transplant(Feb 2013)
- Progressive, well-differentiated non-functional, neuroendocrine tumors (NET) of gastrointestinal (GI) or lung origin with unresectable, locally advanced or metastatic disease (US FDA February 2016).
- Tuberous sclerosis complex-associated partial-onset seizures for adult and pediatric patients aged 2 years and older. (US FDA April 2018).
List Of Generic Brands For Everolimus Tablet In India
If you are looking generic brands for Everolimus Tablet in India. Please contact us at +91 9953466646 or drop us an email at sales@aarkpharma.com. Our representatives will be happy to assist you and answer any questions you may have Everolimus Tablet Price is available at Aark Pharmaceuticals.
